Premium
Immune hemolytic anemia associated with tolmetin and suprofen
Author(s) -
Dijk B. A.,
Rico P. Barrera,
Hoitsma A.,
Kunst V. A. J. M.
Publication year - 1989
Publication title -
transfusion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.045
H-Index - 132
eISSN - 1537-2995
pISSN - 0041-1132
DOI - 10.1046/j.1537-2995.1989.29789369685.x
Subject(s) - medicine , hemoglobinuria , antibody , hemolysis , immune system , hemolytic anemia , autoimmune hemolytic anemia , immunology , autoantibody , coombs test , anemia
This article reports the first case of immune hemolytic anemia possibly associated with the ingestion of suprofen. The patient suffered from massive hemoglobinuria and acute renal failure. Serologic studies of the patient's serum revealed suprofen‐dependent red cell antibodies. However, tolmetin‐dependent antibodies were also found in the serum, showing the same properties as the suprofen antibodies and an even higher titer. The patient not only had drug‐dependent antibodies in the serum, but also had developed autoantibodies, a phenomenon that has been described for several other drugs. The working mechanism by which suprofen and tolmetin caused immune hemolysis had properties of both the immune complex model and the induction of autoimmunity. Although it was unclear whether the immune hemolytic anemia was the result of suprofen, tolmetin, or cross‐reacting antibodies, we feel that suprofen should be added to the list of nonsteroidal anti‐inflammatory drugs associated with a positive direct antiglobulin test.